Most COVID beneficiary stocks in China showcased what they could be in future through their financial results of the COVID-affected first quarter of 2020. Dingdong Maicai’s 1Q20 gross margin of -21%
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.